vimarsana.com
  1. Home
  2. Live Updates
  3. MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan : vimarsana.com

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan ,China ,Tokyo ,Kazuko Matsuda ,Geoff Obrien ,Exchange Commission ,Medicinova Inc ,Japan Patent Office ,Nasdaq ,Nova Receives ,New Patent Covering ,Macular Injury ,Standard Market ,Tokyo Stock Exchange ,Code Number ,Chief Medical Officer ,Optical Coherence Tomography ,Private Securities Litigation Reform Act ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.